References
- 1Organización Mundial de la Salud. IDF Diabetes Advocacy Toolkit – 2017 NCDs Progress Monitor. Geneva; 2017.
- 2Lozano R, Naghavi M. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study. Elsevier; 2010.
- 3WHO-Global Health Observatory data. Premature NCD deaths. WHO.
https://www.who.int/gho/ncd/mortality_morbidity/ncd_premature/en/ . Accessed June 14, 2019. - 4Marquez P, Bank W. The Challenge of Non-Communicable Diseases and Road Traffic Injuries in Sub-Saharan Africa: An Overview. 2013.
- 5Boozary AS, Farmer PE. The Ebola Outbreak, Fragile Health Systems, and Quality as a Cure. JAMA. 2014; 312(18): 1859. DOI: 10.1001/jama.2014.14387
- 6Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007; 85: 279–288. DOI: 10.2471/BLT.06.033647
- 7Chow CK, Ramasundarahettige C, Hu W, et al. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study. Lancet Diabetes Endocrinol. 2018; 6(10): 798–808. DOI: 10.1016/S2213-8587(18)30233-X
- 8Khatib R, McKee M, Shannon H, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet. 2016; 387(10013): 61–69. DOI: 10.1016/S0140-6736(15)00469-9
- 9Cameron A, Ewen M. Medicine prices, availability, and affordability in 36 developing and middle-income countries: A secondary analysis. Lancet. 2009; 373(9659): 240–249. DOI: 10.1016/S0140-6736(08)61762-6
- 10World Health Organisation. Global action plan for the prevention and control of non-communicable diseases 2013–2020. 2013.
- 11MOH R. Republic of Rwanda Non Communicables Disease Policy. Kigali; 2015.
- 12National Institute of Statistics of Rwanda (NISR). Rwanda Demographic and Health Survey, 2014–2015. 2016.
- 13Strasser R, Kam SM. Rural health care access and policy in developing countries. Annu Rev Public Health. 2016; 37(1): 395–412. DOI: 10.1146/annurev-publhealth-032315-021507
- 14Ndayisaba A, Harerimana E, Borg R, et al. A clinical mentorship and quality improvement program to support health center nurses manage type 2 diabetes in rural Rwanda. J Diabetes Res. 2017; 2017: 1–10. DOI: 10.1155/2017/2657820
- 15Bukhman G, Kidder A. The PIH Guide to Chronic Care Integration for Endemic Non-Communicable Diseases. Boston, Massachusetts: Partners In Health; 2011.
- 16Seto MC. Performance Audit Report On Procurement And Management Of Drugs And Medical Supplies And Its Impact On Health Care At University Teaching Hospital- Kigali (UTH-K/CHUK). 2016; 28. DOI: 10.1177/1079063216639485
- 17MoH-Rwanda. National List of Essential Medicines for Paediatrics. Kigali; 2015.
- 18Ewen M, Zweekhorst M. Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases. Podobnik B (ed.), PLoS One. 2017; 12(2): 0171284. DOI: 10.1371/journal.pone.0171284
- 19Bukhman G, Kidder A. PIH Guide to Chronic Care Integration for Endemic Non-Communicable Diseases: Rwanda Edition. Boston, Massachusetts: Patners in Health; 2011.
- 20Lulebo AM, Mutombo PB, Mapatano MA, et al. Predictors of non-adherence to antihypertensive medication in Kinshasa, Democratic Republic of Congo: A cross-sectional study. BMC Res Notes. 2015; 8(1): 526. DOI: 10.1186/s13104-015-1519-8
- 21Mwaka AD, Okello ES. Barriers to biomedical care and use of traditional medicines for treatment of cervical cancer: An exploratory qualitative study in northern Uganda. Eur J Cancer Care (Engl). 2015; 24(4): 503–513. DOI: 10.1111/ecc.12211
- 22Wagenaar BH, Gimbel S, Hoek R, et al. Stock-outs of essential health products in Mozambique – longitudinal analyses from 2011 to 2013. Trop Med Int Heal. 2014; 19(7): 791–801. DOI: 10.1111/tmi.12314
- 23Onchweri Albert OB. Availability of Essential Medicines and Supplies during the Dual Pull-Push System of Drugs Acquisition in Kaliro District, Uganda. J Pharm Care Heal Syst. 2015; 2. DOI: 10.4172/2376-0419.S2-006
- 24Beran D, Ewen M. Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment. Curr Diab Rep. 18(8): 48. DOI: 10.1007/s11892-018-1019-z
- 25Mori AT, Owenya J. Stock-outs of antiretroviral drugs and coping strategies used to prevent changes in treatment regimens in Kinondoni District, Tanzania: A cross-sectional study. J Pharm Policy Pract. 2014; 7(1): 3. DOI: 10.1186/2052-3211-7-3
- 26Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2224–2260. DOI: 10.1016/S0140-6736(12)61766-8
- 27Medicine AOF. Improving Availability and Accessibility of Medicines: A Tool for Increasing Healthcare Coverage. Arch Med. 2015; 7(5): 1–9.
- 28Management Sciences for Health. MDS-3. Managing Access to Medicines and Health Technologies. Arlington, VA. 2012.
- 29WHO. Essential Medicines and Basic Health Technologies for Non-communicable Diseases: Towards a Set of Actions to Improve Equitable Access in Member States. 2015.
- 30MOH-Rwanda. Amendment on the Ministerial Circular No 20/3425/PTF/2009 on the procurement and distribution of medicines and other medical supplies on the national territory. 2020.